Introduction
============

Recent research demonstrated an important impact of psychosocial factors on the development, progression and symptom maintenance of gastrointestinal diseases \[[@b1-cm8702p95],[@b2-cm8702p95],[@b3-cm8702p95],[@b4-cm8702p95],[@b5-cm8702p95]\]. On the other hand, all these factors impair the quality of life of the patients and lead to occupational disability and affect their social relationships \[[@b6-cm8702p95]\]. All these data put into question the biomedical model still used by some physicians to analyze and manage gastrointestinal diseases.

These recent studies caused a shift from this dualist model to a model of reciprocal interaction of physiological and psychological processes. This is an integrative model of psychology and medicine and is called the bio-psychosocial approach of the diseases. For example, peptic ulcer is a very good model for understanding the multifaceted interactions among different factors (psychological, behavioral, social and infectious) in generating an organic disease \[[@b7-cm8702p95]\].

The integrative model is the most accepted model nowadays and it evaluates four categories of factors: disease-related, therapeutical=regimen-related, individual factors and psychopathological comorbidities.

**Biopsychosocial approach of the gastrointestinal disorders** -- the integrative model

1.. Disease-related factors
---------------------------

The **onset** of the gastrointestinal disorder is relevant and it may be: symptomatic or asymptomatic, insidious or acute, traumatic or nontraumatic. In operant behavior terms, the symptoms alleviation will reinforce the behaviour to take the medication. The acute onset is generally perceived as more threatening than the insidious one \[[@b8-cm8702p95]\].

It is important the way the patient's social group perceives the disease: for example hepatitis C viral infection versus cancer. The physician needs to be informed about the disease-related conceptions of the patient and his family, how threatening it is for them, if it is curable etc. For example, there is a general impression about cancer that it is a noncurable disease and because of this conception a lot of patients would not follow the medical recommendatios (he feels it has no utility). The truth is that there are a large number of cases diagnosed in the early stages that can be cured by modern treatments.

Disease **progression** can be uncertain but with some predictable elements, it can be acute or chronic, and its pattern influences the coping process. In acute progression, the intensity of the symptoms is usually greater. The pattern of the disease is influenced by individual pathophysiology, individual response to the treatment, treatment availability, presence of comorbidities, exposure and coping to stress (in some diseases like irritable bowel syndrome, inflammatory bowel diseases, stress modulates the evolution of the illness and the response to the treatment) \[[@b9-cm8702p95]\].

The **symptom types** are also important to assess. The symptom may interfere with the functional independence of the person, it may affect their quality of life or be visible (for example jaundice) and by that it can create a discomfort for the patient in public. The presence of pain is also seen as a negative aspect of the disease and sometimes a condition that produces pain is perceived as more severe than a painless one. The contagiousness of the condition (real or perceived by the patient) and the stigmatization are also important aspects that interfere with the coping process and the compliance to treatment (for example viral hepatitis) \[[@b10-cm8702p95]\].

2.. Therapeutic regimen-related factors
---------------------------------------

**Complexity** of the treatment (number of drugs, scheduling) can reduce the patient's compliance. **Intrusiveness** of the treatment can affect relationships, personal development and intimacy and therefore it can be an impediment for complying with the medical recommendations. **Accessibility, cost** and **adverse reactions** are other important aspects to take into discussion when there is an issue about the compliance of the patient. In fact, the term "compliance" is a paternalist one, like the patients must strictly obey to some medical recommendation. Now the term "self-management" is preferred, because it suggests a patient-centered proactive process that implies certain actions that aim to manage the disease \[[@b11-cm8702p95]\].

### a.. Individual factors

**Intelligence**, level of **education** and of **information** influences the way the patient manages the disease.

The **cultural level** of the patient sometimes can be an obstacle for the physician. The cultural level can be seen from multitude points of view: gender, race, sexual orientation, ethnicity, religion, socioeconomical status, residence, nationality of origin. It influences the risk for certain health problems, access to the health services and the way the patient approach them, interest, confidence, acceptance and adherence to the treatment \[[@b12-cm8702p95]\].

**Confidence** in the doctor and in the medical system can enhance or can be an impediment for obeying to the treatment.

**Beliefs about health and disease** influence the pattern of the disease evolution, the susceptibility to develop a disease or a complication and the adherence to the treatment.

**Individual coping mechanisms** are represented by the primary and secondary appraisal and by the coping style (problem-focused, emotion-focused or avoidance). Both problem-focused and emotion-focuses coping styles have advantages but the context they are employed in is important \[[@b13-cm8702p95]\].

**Social support** has been demonstrated to have an important effect on the disease evolution influencing the endocrine stress reaction, the immune system status and the adjustment and recovery from the illness \[[@b14-cm8702p95]\].

### b.. Psychopathological comorbidities

The majority of the patients with gastrointestinal chronic diseases have depression or anxiety.

**Depression** influences the symptomatology of the disease, its evolution and the adherence to the treatment. A depressed patient will be less motivated to follow the medical recommendation. Anxiety enhances the activity of sympathetic nervous system and interferes with the pathophysiology of certain diseases \[[@b15-cm8702p95]\].

**Substance abuse and dependence** is sometimes overlooked by the doctors. It acts through 4 mechanisms: - the effect of the substance is the main etiological factor for the illness itself: for example alcohol abuse;- the substance has an additional effect to other present risk factors: alcohol raises the risk for hepatocellular carcinoma, just like viral B hepatitis, so an alcoholic patient with viral B infection will have an even higher risk to develop hepatocellular carcinoma;- intoxication with the substance reduces adherence to the treatment or reduces the effect of the treatment: recreational drugs can modify the metabolism of some therapeutical drugs;- i.v. substance use can transmit parenteral infections: for example hepatitis B and C virus.

**Dementia and cognitive impairment** are barriers to the treatment and these patients need help from family members to be able to take the medication correctly.

**Psychosis** influences symptoms and evolution of the disease and the antipsychotic medication is a risk factor for some gastrointestinal problems (for example constipation).

Patients with **personality disorders** have difficulty in establishing a positive relationship with the doctor, they have health risk behaviors, substance abuse behavior, and low social support and reduced adjustment to the disease \[[@b16-cm8702p95]\].

Conclusion
==========

Studies have shown that the psychosocial factors may have a negative or positive impact on health outcome. Until now this relationship has not been completely understood but every information is important when choosing and tailoring therapies (medication and psychological interventions).
